State Medicaid overpays for oxygen DME
This article was originally published in The Gray Sheet
Executive Summary
1HHS Office of Inspector General report claims that in six of nine states audited, Medicaid paid providers $12.7 mil. more than Medicare would have allowed for oxygen-related durable medical equipment. Analyses showed further cost savings could be achieved in the 41 non-audited states. CMS replies it cannot follow OIG's recommendation for alerting states to reduce Medicaid, since "these rates are not dictated or prescribed by CMS"...
You may also be interested in...
Home Oxygen Equipment Payment Reduction, Capped Rentals Needed – OIG
Home oxygen equipment should be subject to competitive bidding and capped rental arrangements in order to lower prices to Federal Employees Health Benefits or Medicare+Choice levels, according to a 1report from the HHS Office of Inspector General
Mustang Bio Enters Race For CAR-T In Autoimmune Disease
The biotech company’s CEO talked to Scrip about plans to bring the CD20-targeting CAR-T MB-106 into an investigator-sponsored Phase I trial later this year.
Aldeyra Hopes To Refile Dry Eye Drug Reproxalap Later In 2024
Following an FDA complete response letter last November, Aldeyra has agreed with the agency on a trial design to demonstrate efficacy in ocular discomfort, which the company can complete this year.